Current Cancer Drug Targets

Ruiwen Zhang 
Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106


Development and Assessment of Conventional and Targeted Drug Combinations for Use in the Treatment of Aggressive Breast Cancers

Volume:6   Issue:6
Pp: 455-489
D. N. Waterhouse, K. A. Gelmon, R. Klasa, K. Chi, D. Huntsman, E. Ramsay, E. Wasan, L. Edwards, C. Tucker, J. Zastre, Y. Z. Zhang, D. Yapp, W. Dragowska, S. Dedha and M. B. Bally
DOI: 10.2174/156800906778194586

Order Reprints Order Eprints

Synthetic Glycopeptides from the Mucin Family as Potential Tools in Cancer Immunotherapy

Volume:6   Issue:6
Pp: 491-517
Torsten Becker, Sebastian Dziadek, Sven Wittrock and Horst Kunz
DOI: 10.2174/156800906778194577

Order Reprints Order Eprints

Protein Tyrosine Phosphatases, New Targets for Cancer Therapy

Volume:6   Issue:6
Pp: 519-532
David Easty, William Gallagher and D. C. Bennett
DOI: 10.2174/156800906778194603

Order Reprints Order Eprints

Knowledge of Epigenetic Influence for Prostate Cancer Therapy

Volume:6   Issue:6
Pp: 533-551
Masatoshi Watanabe, Akimitsu Takagi, Takeshi Matsuzaki, Daisuke Kami, Minoru Toyota, Yoshifumi Hirokawa and Taizo Shiraishi
DOI: 10.2174/156800906778194568

Order Reprints Order Eprints